Skip to main content
Fig. 6 | Breast Cancer Research

Fig. 6

From: Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer

Fig. 6

Insulin-like growth factor 1 receptor (IGF1R) expression according to estrogen receptor (ER) status. a Low IGF1R level/ER-positive group. b High IGF1R level/ER-positive group. c Low IGF1R level/ER-negative group. d High IGF1R level/ER-negative group. pCR pathologic complete response

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us